Meriwether Wealth & Planning’s ARK Genomic Revolution ETF ARKG Stock Holding History

Meriwether Wealth & Planning’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.13K	Buy	+150	New	+$6.74K	﹤0.01%	453

Other funds holding ARKG

NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return

Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return

Canal Insurance Company Greenville, South Carolina $426M AUM 30.47% 1-Year Est. Return

Gimbal Financial Carmel, Indiana $172M AUM

Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

Global View Capital Management Waukesha, Wisconsin $449M AUM 34.17% 1-Year Est. Return

Brookstone Capital Management Wheaton, Illinois $10.1B AUM 17.94% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.18B AUM 13.12% 1-Year Est. Return

Meriwether Wealth & Planning's ARKG Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 150 shares worth $8.13K. The stake represents ﹤0.01% of the portfolio and ranks #453 among its holdings.

98 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

Meriwether Wealth & Planning held 150 shares of ARK Genomic Revolution ETF worth $8.13K as of Q3 2026.
ARK Genomic Revolution ETF was a new Meriwether Wealth & Planning position in Q3 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #453 holding.
98 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.